Compare 12 GLP-1 programs for women by pricing, medical oversight, menopause-related support, medication options, and safety to find care suited to individual health needs.
Women are more likely than men to use GLP-1 medications in certain age groups, with the highest reported lifetime usage among women aged 50–64 in RAND's 2025 research. Many women are also navigating midlife weight changes during this period. However, telehealth weight loss platforms vary in how they address the hormonal, metabolic, and health concerns specific to women during perimenopause, menopause, and other life stages. Majesta Health is a LegitScript-certified telehealth platform built specifically around women's health, connecting patients with US-licensed physicians for GLP-1 weight loss evaluation and treatment when appropriate.
Finding the right GLP-1 program means looking beyond the prescription itself. The best programs for women combine transparent pricing, genuine physician oversight, women-centered clinical expertise, and ongoing support that addresses the unique factors affecting weight management throughout a woman's life.
This guide reviews 12 leading GLP-1 telehealth programs for women, with evaluation criteria focused on clinical quality, pricing transparency, women-specific features, and program comprehensiveness. Pricing and availability reflect information available in November 2026 and may change during 2027.
Key Takeaways
- Women are more likely than men to have used GLP-1 medications in certain age groups, with the highest lifetime usage among women aged 50 to 64 in RAND's 2025 survey.
- GLP-1 programs for women should consider hormonal health, offer transparent pricing, and provide genuine clinical oversight rather than relying solely on automated prescribing.
- Majesta Health emphasizes a women-centered approach, all-inclusive pricing, LegitScript certification, named pharmacy partners, and US-licensed physicians whose credentials can be publicly verified.
- Programs vary significantly in their support models, ranging from comprehensive behavioral and medical hybrids to medication-focused telehealth platforms.
- Eligible Medicare Part D beneficiaries can explore the Medicare GLP-1 Bridge, which began in July 2026 and is scheduled to run through December 2027.
- Before choosing any program, check applicable credentials, confirm the dispensing pharmacy, and ensure a qualified, licensed prescriber will review your medical history.
Best Online GLP-1 Programs for Women at a Glance
The programs below serve different weight management needs. Some specialize in menopause and women's hormonal health, while others focus on medication access, insurance coordination, or behavioral support.
| Program | Best for | Why |
|---|---|---|
| Majesta Health | All-inclusive pricing and named clinical partners | One monthly price includes physician consultation and, if prescribed, medication and shipping. Enrollment has not opened. |
| Midi Health | Insurance-covered visits and hormone therapy | Menopause and weight management care on one platform, with no membership fee. |
| Alloy Health | Menopause-specialist care | Menopause-focused clinicians provide hormone therapy and GLP-1 treatment. |
| Evernow | Affordable menopause membership | Lower-cost annual membership with access to menopause care and insurance-covered video visits. |
| Maven Clinic | Medication with nutrition and strength coaching | FDA-approved GLP-1 options alongside women's health and lifestyle support. |
| Gennev | Dietitian-led weight management | Nutrition-focused care with clinicians trained in obesity medicine. |
| Hers | Women-focused medication options | Named FDA-approved oral and injectable medications alongside separate menopause care. |
| Ro | Insurance coverage assistance | Coverage checks and prior authorization support for eligible medications. |
| Mochi Health | Unlimited visits and nutrition support | Provider consultations and nutrition services within membership options. |
| Found | Medication-inclusive cash plans | Compounded medication included in qualifying plans, with insurance assistance available. |
| Noom Med | Behavioral coaching | Psychology-based habit-change support alongside medication. |
| WeightWatchers Clinic | Community and behavioral support | Nutrition counseling, app-based tools, and established community resources. |
These descriptions reflect published program features, not independently measured treatment outcomes. The best fit depends on individual health needs, medication eligibility, insurance, and total cost.
What to Look For in a GLP-1 Program for Women
GLP-1 programs designed for women should address more than weight loss. They should account for hormonal fluctuations, metabolic changes during midlife, and the importance of preserving muscle and bone health during treatment.
Here are the key criteria to evaluate:
Clinical Support and Physician Oversight
- Actual medical review: A licensed prescribing clinician should evaluate your medical history, current medications, and health goals before any prescription is written. Programs that rely solely on chatbots or automated questionnaires without clinician involvement may not provide adequate medical oversight.
- Ongoing care: Look for programs that include regular check-ins, medication adjustment support, and care team messaging rather than one-time prescriptions.
- Women's health expertise: Providers with experience in perimenopause, menopause, thyroid conditions, and hormonal health can better address the specific factors affecting weight management in women.
Pricing Transparency
- All-inclusive pricing: Some programs include physician consultation, medication, and shipping in one monthly fee, while others charge separately. Check the complete cost before enrolling.
- Cancellation terms: Verify that cancellation policies are clearly stated and accessible before you enroll.
- Named pharmacy: Programs should identify the licensed pharmacy responsible for dispensing medication and make relevant pharmacy information available to patients.
When comparing prices, account for membership fees, medication charges, shipping, consultations, and laboratory costs. Also check whether the program bills monthly, every 28 days, or through a longer prepaid commitment.
Medication Options and Safety
- Compounded vs. FDA-approved medications: Understand whether the program offers compounded GLP-1 medications, FDA-approved medications, or both. Each has different regulatory pathways and cost structures.
- 503A or 503B facilities: When compounded medications are involved, confirm that they come from appropriately licensed pharmacies or registered outsourcing facilities operating under applicable federal and state requirements.
- Safety disclosures: Responsible programs provide clear information about potential side effects, contraindications, and when to seek medical attention.
Compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication. The FDA explains that compounded medications do not undergo its premarket review for safety, effectiveness, and quality.
Women-Specific Considerations
- Hormonal health integration: Programs that consider hormone replacement therapy, contraception, pregnancy plans, and menopause-related metabolic changes can provide more complete evaluations. Evidence on combining GLP-1 treatments with menopause hormone therapy remains limited.
- Muscle and bone preservation: Midlife women should look for programs that address maintaining lean muscle mass and bone health during weight loss.
- Individual review: Women's weight management needs vary significantly by age, hormonal status, and health history, so a qualified clinician should review each woman's history before any treatment decision.
Contraception and pregnancy considerations: Women who use oral hormonal contraception should discuss medication-specific interactions with their prescriber. The Zepbound prescribing information warns that tirzepatide may reduce the effectiveness of oral hormonal contraceptives. It advises switching to a non-oral method or adding a barrier method for four weeks after starting treatment and after each dose escalation.
FDA-approved semaglutide and tirzepatide weight management products also carry pregnancy-related warnings. Wegovy's prescribing information advises discontinuing semaglutide at least two months before a planned pregnancy. Women who are pregnant, planning pregnancy, or breastfeeding should discuss these considerations with their prescribing clinician.
These precautions are drawn from FDA-approved product information and should not be treated as evidence that a compounded formulation has identical safety or effectiveness.
Certification and Cancellation Policies
Independent certifications can help patients evaluate a telehealth provider's compliance practices. LegitScript certification is one credential worth checking, although certification does not replace medical licensing, pharmacy verification, or individualized clinical assessment.
Before enrolling, patients should also confirm cancellation procedures, renewal terms, potential fees, and refund policies. Prepaid memberships and introductory offers may carry different obligations from month-to-month plans.
1) Majesta Health
Best for: All-inclusive monthly pricing with named pharmacy partners and independent physician oversight.
Majesta Health is a LegitScript-certified telehealth platform focused on doctor-guided GLP-1 weight management for women. The platform plans to offer compounded semaglutide and tirzepatide injections through independent US-licensed physicians and state-licensed compounding pharmacy partners. As of November 16, 2026, enrollment had not opened, and an early-access waitlist was available.
Why It Fits Women
Majesta Health was built with a mission to help women feel informed, respected, and heard throughout their weight management journey. Ksenia Petrushkina, PA-C, co-founder of Majesta Health, brings 15 years of experience in science, alongside clinical experience in medical weight management, GLP-1 therapy, metabolic health, and women's hormonal health, including perimenopause, menopause, and thyroid disorders.
An independent physician licensed in the patient's state reviews each woman's goals, medical history, medications, and relevant clinical factors, and decides whether treatment is appropriate. Majesta Health itself does not prescribe or dispense medications.
Women-Relevant Capabilities
- All-in pricing: One monthly price with no separate enrollment fees or hidden charges. Majesta's November 16, 2026 company-confirmed update lists the Essential Plan, featuring compounded Semaglutide/Glycine/B12 Injection, at $159 for the first month and $289 per month thereafter. The Performance Plan, featuring compounded Tirzepatide/Glycine/B12 Injection, is $269 for the first month and $399 per month thereafter.
- Named accountability: The platform identifies Belmar Pharma Solutions and Strive Pharmacy as compounding pharmacy partners and lists a care team of US-licensed physicians whose credentials can be publicly verified. The specific dispensing pharmacy for an individual prescription is determined separately.
- Compliance-first positioning: Majesta Health publishes FDA-status disclosures explaining that compounded medications are not FDA-approved as final products. The platform is LegitScript-certified.
- Women-centered clinical approach: The platform explicitly addresses the needs of women navigating weight management during perimenopause, menopause, and other hormonal transitions.
- Planned Express option: Express is a proposed compounded oral option featuring Tirzepatide LPT® Chewable Tablets. Its proposed price is $249 for the first approved 30-day care cycle and $339 per approved 30-day care cycle thereafter. Express is not yet available for purchase, and its final pricing, availability, and care terms will be confirmed before enrollment.
What Women Should Know
Majesta Health is currently in pre-launch status with an early-access waitlist active. Enrollment had not opened as of November 16, 2026. Joining the waitlist does not require payment and does not constitute a medication order. Treatment will become available in eligible states once enrollment opens, subject to evaluation and approval by an independent, licensed physician. Nothing is charged until a physician reviews and approves treatment.
The planned injection plans include physician consultation, monthly check-ins, care-team messaging, prescribed medication when approved, and shipping. The $20 physician consultation fee is included in the plan price rather than charged separately. Majesta does not bill insurance.
Availability depends on state-specific requirements. Louisiana and Mississippi are on waitlist-only status, and readers should confirm whether treatment is available in their state when enrollment opens.
Majesta offers compounded medication rather than FDA-approved brand-name GLP-1 products. It does not offer menopause hormone therapy or insurance billing. Women seeking those services may find other programs in this comparison more suitable.
Compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication.
2) Midi Health
Best for: Insurance-covered consultations and coordinated menopause and weight management care.
Midi Health is a women's telehealth company focused on perimenopause and menopause care that also offers weight management, including GLP-1 prescriptions.
Why It Fits Women
Midi's weight program is designed for women and links midlife weight changes to hormonal shifts during perimenopause and menopause. Hormone therapy and weight care are available on the same platform, subject to individual clinical evaluation.
Midi describes its clinicians as receiving specialized training in women's health and weight management.
Women-Relevant Capabilities
- FDA-approved GLP-1 medications sent to the patient's pharmacy, plus compounded options in certain injectable and other formulations
- Labs such as blood sugar and cholesterol tests to assess metabolic health
- Perimenopause and menopause hormone therapy available through the same platform
- Virtual visits with licensed clinicians, including nurse practitioners and certified nurse midwives
- Initial consultations lasting approximately 30 minutes and follow-up visits of approximately 15 minutes, according to the platform's published care model
What Women Should Know
Midi is in-network with many major insurance plans for visits. Self-pay visits are $250 for the initial consultation and $150 for returning visits, while compounded GLP-1 medications start at $164 per four-week supply, with medication billed separately from visits (checked November 13 and 16, 2026).
Midi does not charge a separate membership fee.
GLP-1 prescriptions are not always covered by insurance. Midi does not participate in Medicaid or Medicare billing, although Medicare beneficiaries may access certain services as self-pay patients. Services are offered nationwide, with treatment and insurance availability depending on the patient's state and plan.
3) Alloy Health
Best for: Menopause-specialized clinicians who provide hormone therapy and GLP-1 treatment.
Alloy Health is a telehealth platform built specifically for menopause care that has expanded into weight management services.
Why It Fits Women
Founded by women for menopause care, Alloy explicitly positions its weight care as designed for midlife. The platform connects patients with menopause-specialized clinicians who consider how hormonal shifts may affect metabolism, appetite, and fat distribution.
Alloy describes its physicians as board-certified and specializing in menopause and midlife care. Patients may receive menopause hormone therapy and GLP-1 treatment through the same platform when clinically appropriate.
Women-Relevant Capabilities
- Menopause-specialized physicians
- Ability to coordinate weight management and menopause hormone therapy when appropriate
- Individualized treatment decisions for midlife women
- Compounded and FDA-approved medication options, depending on eligibility and availability
- Ongoing messaging with a dedicated physician to discuss medication adjustments and treatment concerns
What Women Should Know
Alloy charges $99 per month for its Weight Care program, with compounded semaglutide starting at $70 per month, billed separately (checked November 13, 2026).
The service is cash-pay and does not accept insurance, although HSA and FSA cards are accepted for eligible patients.
Weight Care is available in most states but not Louisiana or Mississippi. In Alabama, Arkansas, California, Nevada, and Washington, DC, Alloy offers FDA-approved medication options only.
Alloy's menopause-first approach may be particularly relevant for women seeking coordinated discussions about weight management and menopause symptoms.
4) Evernow
Best for: An affordable menopause-focused membership with access to hormone therapy and insurance-covered video visits.
Evernow is a menopause telehealth service that offers care for perimenopause and menopause symptoms, including hormone therapy, non-hormonal treatment, and weight management support.
Why It Fits Women
Evernow approaches weight management as one component of menopause care. Women can access hormone therapy and GLP-1 treatment through the same platform when clinically appropriate.
This model may appeal to women who want help managing menopause symptoms alongside changes in weight, appetite, or metabolic health.
Women-Relevant Capabilities
- FDA-approved GLP-1 medications, including Wegovy and Zepbound, when prescribed by a clinician
- Compounded medication options described in the platform's published weight care information
- Menopause hormone therapy and non-hormonal symptom treatment through the same platform
- Named pharmacy partners, including GoGo Meds and Art of Medicine
- Video visits that may be covered by participating commercial insurance plans
What Women Should Know
Evernow's membership costs $49 per month, $129 for three months, or $420 for 12 months paid upfront, equivalent to $35 per month (checked November 13, 2026).
Video consultations are billed separately to participating insurance plans or cost $150 per visit for self-pay patients. GLP-1 medication costs are also separate, and the platform does not publish a universal medication price.
Evernow accepts certain major commercial insurance plans for eligible video visits but does not accept Medicare or Medicaid.
The service is available across all 50 states and Washington, DC, subject to individual treatment availability and clinical eligibility.
5) Maven Clinic
Best for: FDA-approved GLP-1 medication with nutrition, strength training, and women's hormonal health support.
Maven Clinic is a women's and family health telehealth platform offering reproductive, maternity, fertility, menopause, and metabolic health support, including GLP-1 treatment.
Why It Fits Women
Maven was founded in 2014 as a telehealth platform for women and has since expanded to cover different stages of women's and family health. It considers GLP-1 treatment in the context of broader metabolic, reproductive, and hormonal health needs.
Maven describes its GLP-1 approach as hormone-aware, with support for weight management and menopause-related concerns.
Women-Relevant Capabilities
- Women's and reproductive health expertise relevant to GLP-1 treatment decisions
- Support addressing exercise, diet, sleep, and metabolic health alongside medication-related questions
- Consideration of fertility treatment, pregnancy planning, and menopause in clinical discussions
- Nutrition and strength coaching, including an initial consultation under the program's published terms
- FDA-approved GLP-1 medication options rather than compounded formulations
- Access to clinician calls and messaging
What Women Should Know
Maven's GLP-1 program membership costs $39 for the first month, followed by $74 per month on a 12-month plan, $89 per month on a six-month plan, or $99 per month on a three-month plan.
Medication is billed separately by the patient's pharmacy, starting at $149 per month (checked November 13, 2026).
The total cost depends on the membership commitment and prescribed medication. Women should verify their eligibility and the applicable treatment terms before enrolling.
6) Gennev
Best for: Dietitian-led weight management with access to physicians trained in obesity medicine.
Gennev is a menopause-focused telehealth clinic that offers weight management support through registered dietitians and prescribing clinicians.
Why It Fits Women
Gennev emphasizes nutrition and metabolic health as part of weight management during midlife.
Its care model begins with a dietitian consultation rather than immediately focusing on medication. Gennev states that its physicians receive training through the Obesity Medicine Association, with some holding certification from the American Board of Obesity Medicine.
Women-Relevant Capabilities
- Initial consultations with registered dietitians and ongoing nutrition support
- Recommended follow-up visits to review progress and adjust nutrition strategies
- Metabolic laboratory assessments when clinically appropriate
- Access to FDA-approved GLP-1 medications such as Wegovy and Zepbound when prescribed
- Separate menopause care services, including hormone therapy
What Women Should Know
Gennev does not charge a monthly membership fee.
Self-pay consultations cost $119 to $250 per visit, depending on the clinician and type of appointment. Medication costs are separate and are not listed as a fixed monthly price (checked November 13, 2026).
Gennev accepts many Aetna, Anthem, and UnitedHealthcare plans for eligible visits, although individual coverage depends on the patient's benefits.
The service is available nationwide. Its weight management program focuses on obesity care rather than diabetes management, and the platform does not position compounded GLP-1 medications as a routine treatment option.
7) Hers
Best for: Women-focused weight care with clearly identified FDA-approved oral and injectable medication options.
Hers is the women-focused telehealth brand of Hims & Hers, offering online weight care with FDA-approved GLP-1 medications in pill and injection form.
Why It Fits Women
Hers serves women through its weight management services, and its broader platform also offers separate perimenopause and menopause care delivered online. A woman managing weight and midlife hormone changes can access both types of care through the same brand, subject to clinical eligibility and availability.
The weight management and menopause services are separate, so patients should confirm whether care can be coordinated across them.
Women-Relevant Capabilities
- FDA-approved GLP-1 medications, including semaglutide, tirzepatide, and orforglipron options in applicable pill and injection forms
- 24/7 messaging with licensed providers and side effect support
- Separate perimenopause and menopause care, including hormone therapy when a provider prescribes it
- Optional smart scale for weight tracking, subject to availability and membership terms
What Women Should Know
The Hers Weight Loss Membership costs $39 for the first month and $149 per month afterward, with medication billed separately. Medication starts at $149 per month for the Wegovy pill or Foundayo, $199 per month for the Wegovy pen, and $299 per month for Zepbound, at the starting dose, with a prescription and an active membership (checked November 16, 2026).
Hers does not require insurance for its self-pay program, and certain services are not available in all 50 states. The platform primarily advertises FDA-approved GLP-1 options, with medication selection determined by a licensed provider.
8) Ro
Best for: Insurance coverage assistance and access to FDA-approved GLP-1 medications.
Ro is a direct-to-patient telehealth company whose Ro Body membership provides access to FDA-approved GLP-1 medications, provider care, and assistance with insurance coverage.
Why It Fits Women
Ro is a general weight care program rather than a women-specific one. Women who want to use insurance can get a coverage check and help with prior authorization paperwork, and women paying cash can review medication prices before starting.
Women-Relevant Capabilities
- FDA-approved GLP-1 medications in pill and injection form
- Free insurance checks for eligible medications, with prior authorization paperwork handled for members
- Unlimited provider messaging, side effect support, regular check-ins, and 1:1 health coaching
- Care from licensed clinicians, beginning with an online evaluation
What Women Should Know
The Ro Body membership costs $39 for the first month, then $149 per month on a monthly plan or $74 per month on a prepaid annual plan. Medication is billed separately, starting at $149 per month (checked November 13, 2026).
Ro offers additional prepaid membership options, and medication costs depend on the product, insurance coverage, and available discounts. Ro offers care nationwide, although specific medications and services vary by state. Ro does not offer a dedicated menopause or PCOS weight management program.
Ro's published terms also describe a refund of the initial membership payment for patients found ineligible for GLP-1 treatment, subject to the program's conditions.
9) Mochi Health
Best for: Unlimited provider consultations and nutrition support through a telehealth membership.
Mochi Health is a telehealth weight management membership providing access to FDA-approved and, when appropriate under applicable requirements, compounded GLP-1 medications after an evaluation with a licensed provider.
Why It Fits Women
Mochi is a general weight management program, but its provider network includes clinicians with backgrounds in family medicine, internal medicine, obesity medicine, and other specialties. Its services can support women with different weight management and metabolic health concerns.
Mochi also offers separate menopause-related care, including hormone therapy when clinically appropriate.
Women-Relevant Capabilities
- FDA-approved GLP-1 medications in pill and injection form, plus individualized compounded options when appropriate
- Unlimited provider video visits under applicable self-pay memberships
- Nutrition and wellness support through its membership options, with registered dietitian access depending on the plan
- Optional lab panels and assistance with insurance prior authorizations
- Access to separate menopause-related health services, with availability depending on the program
What Women Should Know
Mochi's self-pay membership costs $79 per month, or $49 per month on a 12-month plan, with medication billed separately (checked November 13, 2026). An insurance-based membership option starts at $17 per month, subject to eligibility.
Mochi serves patients across the United States, although medication availability, pricing, and eligible services vary by state. Compounded medications are not FDA-approved as final products, and an eligible prescription is not guaranteed.
10) Found
Best for: Medication-inclusive cash plans or insurance assistance, including support for eligible Medicare GLP-1 Bridge participants.
Found is a medical weight management telehealth platform that emphasizes clinical support and personalized treatment paths.
Why It Fits Women
The program uses clinicians with obesity medicine experience and offers a personalized assessment approach.
Found has also announced plans for menopause-related hormone therapy services, although availability is subject to the platform's rollout and eligibility requirements.
Women-Relevant Capabilities
- Clinicians with obesity medicine expertise
- Multiple treatment options through its formulary
- Health coaching and lifestyle resources alongside clinical oversight
- Regular clinical check-ins and plan adjustments
- Side effect support
- Assistance for eligible Medicare Part D beneficiaries accessing the Medicare GLP-1 Bridge
What Women Should Know
Found's cash-pay plans start at $149 per 28-day care cycle for the first 12-month term paid upfront ($169 per cycle upon renewal), or $269 per 28-day cycle on a month-to-month plan. Insurance-based plans start at $79 per 28-day cycle for the first 12-month term paid upfront ($99 per cycle upon renewal), or $199 per cycle month to month. Compounded GLP-1 medication is included, while insurance visits may carry additional copays, coinsurance, or deductibles (checked November 17, 2026).
Compounded medication is included in these plans, while brand-name medication is billed separately (medication inclusions checked November 13, 2026).
Found offers an insurance coverage checker. A 28-day billing cycle differs from a calendar month and can result in 13 billing cycles over 364 days. The prepaid plan requires upfront payment for its stated commitment. Women should review total charges and cancellation terms before enrolling.
11) Noom Med
Best for: Behavioral coaching and habit-change support alongside GLP-1 treatment.
Noom Med adds GLP-1 medication access to Noom's established psychology-based weight loss approach.
Why It Fits Women
Noom's cognitive behavioral therapy principles address the emotional and psychological aspects of eating, which may be relevant to women seeking behavioral support. The platform combines medication with behavioral guidance designed to build sustainable habits.
Noom also offers a separate menopause-related care program.
Women-Relevant Capabilities
- Cognitive behavioral therapy principles
- Behavioral coaching combined with medication
- Coaching, recipes, and exercise resources
- App-based tracking and progress monitoring
- Focus on mindset shifts alongside medication
- Separate menopause services and information about Medicare GLP-1 Bridge access
What Women Should Know
Noom offers several GLP-1Rx programs that include compounded medication when prescribed. According to its official pricing page, the Microdose GLP-1Rx program starts at $79, followed by $179 per month, while the standard GLP-1Rx program starts at $129, followed by $249 per month. GLP-1Rx Plus starts at $149, followed by $299 per month. These plans include medication, clinical care, and digital support, with subsequent subscriptions billed quarterly (checked November 17, 2026).
Noom's homepage has also advertised different introductory and recurring prices, so published offers may vary by program or enrollment pathway.
Brand-name medication access through Noom Med starts at $39, with the prescribed medication charged separately. The dedicated pricing page lists ongoing telehealth care at $129 per month, billed quarterly after the first month.
Women should confirm their exact subscription terms, recurring charges, medication type, taxes, and state availability before enrolling.
12) WeightWatchers Clinic
Best for: Established behavioral weight management support and community resources alongside clinical care.
WeightWatchers Clinic combines the company's established behavioral weight loss program with GLP-1 medication access through telehealth.
Why It Fits Women
WeightWatchers has served women for decades, giving the organization extensive experience with behavioral weight management. Its GLP-1 Success Program adds medication-related support to the behavioral and community resources the brand is known for.
The platform also offers separate menopause-related services.
Women-Relevant Capabilities
- More than 60 years of behavioral weight management experience
- GLP-1 Success Program
- Nutrition counseling and registered dietitian access under eligible plans
- Community support through the Connect platform
- App-based engagement and progress monitoring
- Assistance for eligible Medicare GLP-1 Bridge participants
- FDA-approved oral and injectable GLP-1 medication options
What Women Should Know
WeightWatchers Med+ costs $25 for the first month on a six- or 12-month plan, followed by $74 per month on the 12-month plan or $84 per month on the six-month plan. GLP-1 medications are billed separately, and plans renew automatically for the same term unless canceled (checked November 17, 2026).
GLP-1 medication is billed separately, with self-pay medication starting at $149 per month (checked November 13, 2026).
Women who value community support and behavioral coaching alongside medication may find this combination approach appealing. The total cost depends on the membership, selected medication, eligibility, and applicable promotional terms.
What Each GLP-1 Program Costs?
| Program | Program fee | Medication | Insurance |
|---|---|---|---|
| Majesta Health (enrollment not yet open) | Essential: $159 first month, then $289 a month. Performance: $269, then $399 a month. Planned Express: $249 for the first approved 30-day care cycle, then $339 per approved 30-day care cycle | Included, if prescribed; see formulas below | Not billed |
| Midi Health | No membership. Visits $250 first, $150 after, or insurance | Separate. Compounded sublingual from $164 or injectable from $165.90 per 4 weeks | Most major insurers for visits; not Medicare or Medicaid |
| Alloy | $99 a month | Separate. Compounded semaglutide from $70 a month | Not accepted directly; eligible HSA/FSA expenses may qualify |
| Evernow | $49 a month, $129 for three months, or $420 for 12 months paid upfront ($35 a month). | Separate; prices not listed | Major commercial plans for video visits, or $150 a visit |
| Maven Clinic | $39 first month, then $150 a month on the monthly plan. Prepaid plans: $74 a month annually, $89 a month for 6 months, or $99 a month for 3 months | Separate. FDA-approved medication from $149 a month, billed by the pharmacy | Medication coverage depends on the patient's insurance |
| Gennev | No membership. Visits $119 to $250, or insurance | Separate; price not listed | Most Aetna, Anthem and UnitedHealthcare plans |
| Hers | $39 first month, then $149 a month | Separate. Wegovy pill or Foundayo from $149 a month; Wegovy pen from $199; Zepbound from $299 | Self-pay; HSA/FSA eligibility may apply |
| Ro | $39 first month, then $149 a month, or $74 a month on a prepaid annual plan | Separate. Wegovy pill or Foundayo from $149 a month; injectables cost more | Coverage check and paperwork included |
| Mochi Health | $79 a month, or $49 a month on a prepaid 12-month plan ($588 annually) | Separate. See Mochi's current medication menu | Prior-authorization help; eligible insurance-based membership from about $17 a month ($199 annually), with possible visit costs |
| Found | Cash plans: $149 per 28-day cycle for the first 12-month term ($169 at renewal), or $269 month to month | Compounded medication included in qualifying plans; brand-name medication billed separately | Insurance plans: $79 per cycle for the first prepaid 12-month term ($99 at renewal), or $199 per cycle month to month, plus applicable visit costs |
| Noom Med | Microdose GLP-1Rx: $79 initially, then $199 a month. Standard GLP-1Rx: $129 initially, then $249 a month. GLP-1Rx Plus: $149 initially, then $299 a month | Compounded medication included in qualifying GLP-1Rx plans. Brand-name access from $39 for telehealth, plus medication | Insurance checker offered |
| WeightWatchers Clinic | Med+: $25 first month, then $74 a month on a 12-month plan or $84 a month on a 6-month plan; renews automatically | Separate, self-pay medication from $149 a month | Insurance coordination offered |
Published provider pricing checked November 13 and 16, 2026, as documented in the client-reviewed comparison. Express pricing is proposed and not a currently purchasable offer. Prices vary by medication, dose, eligibility, commitment, and promotions.
Important billing distinctions: Found quotes fees per 28-day cycle, not calendar month. Prepaid annual plans require payment in advance, and 13 four-week billing cycles span 364 days. Noom's introductory GLP-1Rx offer covers an initial three-week subscription with four weeks of medication, followed by a longer subscription.
The total cost should be checked directly with the provider before enrollment.
Why Majesta Health Stands Out for Women Seeking GLP-1 Treatment
While several telehealth platforms offer GLP-1 medications, Majesta Health distinguishes itself through a combination of features specifically designed for women's needs.
Women-Centered Clinical Foundation
Majesta Health was built from the ground up with women's health as its central focus. Co-founder Ksenia Petrushkina, PA-C, brings clinical experience in women's hormonal health, including perimenopause, menopause, and thyroid disorders, alongside 15 years of experience in science. This foundation informs the platform's focus on women-centered education and physician-guided care.
The platform's mission explicitly emphasizes helping women feel informed, respected, and heard, acknowledging the importance of listening to women's experiences when they seek medical support for weight management.
All-In Pricing
Majesta Health's planned treatment model includes physician consultation, prescribed medication when approved, and shipping in one monthly fee. There are no separate enrollment fees, membership tiers, or hidden charges for its injection plans.
According to the November 16, 2026 company-confirmed pricing, Essential is $159 for the first month and $289 per month afterward, while Performance is $269 for the first month and $399 per month afterward.
The planned Express oral option has proposed pricing of $249 for the first approved 30-day care cycle and $339 per approved 30-day cycle afterward. Express is not yet available, and its final pricing and enrollment terms remain subject to confirmation.
The pricing page explains the program's billing structure, and nothing is charged until an independent physician reviews and approves treatment.
Compliance-First Positioning
Majesta Health identifies Belmar Pharma Solutions and Strive Pharmacy as state-licensed compounding pharmacy partners. Its care team page provides information about independent, US-licensed physicians. Their credentials can be checked through relevant state medical boards and public NPI records.
Majesta Health discloses that compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with FDA-approved medications. The platform achieved LegitScript Healthcare Merchant Certification on August 26, 2026.
What to Know Before Joining the Waitlist
Majesta Health is currently pre-launch, with enrollment not yet open as of November 16, 2026. Women can complete the two-minute assessment and join the early-access waitlist without payment or a medication order.
Treatment availability depends on the patient's state, and Louisiana and Mississippi remain waitlist-only. Once enrollment opens, an independent, US-licensed physician must determine whether treatment is appropriate. No prescription is guaranteed.
Majesta does not offer FDA-approved brand-name GLP-1 medications, menopause hormone therapy, or insurance billing. Women who need those services should compare the alternatives above.
Compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication. Treatment requires physician approval, and individual results vary.
Take the 2-minute assessment to join early access and explore whether physician-guided treatment may be appropriate once enrollment opens.
How These GLP-1 Programs Were Compared
This comparison includes telehealth programs offering GLP-1-related weight management services to adults in the United States, with an emphasis on platforms serving women or offering relevant clinical support.
The programs were evaluated using their published information on medical oversight, medication options, pricing, insurance arrangements, menopause-related services, and ongoing care.
Provider pricing and program details were reviewed using the client-verified source information dated November 13 and 16, 2026. Features reflect what the platforms publicly described at those dates.
This review does not represent firsthand enrollment, independent testing of patient care, or clinical comparisons of medication effectiveness. The order groups women-centered platforms before broader weight management providers, with Majesta Health listed first because it publishes this guide.
Before You Change Anything
Discuss your medical history, current medications, pregnancy plans, and possible contraindications with a licensed healthcare professional before considering GLP-1 medication. If you are pregnant, planning pregnancy, or using hormonal contraception, ask about medication-specific precautions.
When to Get Help Right Away
Seek urgent medical attention for severe or persistent abdominal pain, especially when accompanied by vomiting. Call 911 for chest pain, difficulty breathing, fainting, or signs of a severe allergic reaction. Contact your prescribing clinician promptly concerning treatment-related symptoms.
This article is for informational purposes only and does not constitute medical advice, diagnosis or treatment. It does not recommend starting, stopping or changing any medicine.
Sources checked November 17, 2026. Provider pricing reflects the client-reviewed information from November 13 and 16, 2026.
Frequently Asked Questions
What is the best online GLP-1 program for women?
There is no single best program for every woman. The appropriate choice depends on budget, insurance coverage, medical history, and the type of care needed. For menopause and weight management care on one platform, Midi Health, Alloy Health, Evernow, and Maven Clinic offer relevant services. For insurance assistance, Ro, Mochi Health, and Found provide coverage-related support. Majesta Health offers planned all-inclusive compounded injection plans but had not opened enrollment as of November 16, 2026. Found and Noom also offer qualifying plans that include compounded medication. A licensed prescriber should assess treatment suitability before any prescription is issued.
How much does an online GLP-1 program cost?
Costs vary by care model, medication, and billing arrangement. Some programs charge a membership fee with medication billed separately, while others offer medication-inclusive plans. Among the programs reviewed, Found's prepaid cash-pay plans start at $149 per 28-day cycle. Majesta Health's planned Essential injection plan starts at $159 for the first month and costs $289 per month afterward. Its Performance plan starts at $269 and costs $399 per month afterward. Majesta's planned Express option has proposed pricing of $249 for the first approved 30-day cycle, then $339 per approved cycle. Final pricing remains subject to confirmation before enrollment. Programs charging by consultation may cost $119–$250 per self-pay visit, with medication billed separately. Readers should compare the complete recurring cost, not just promotional starting prices.
How are compounded GLP-1 medications regulated?
Compounded GLP-1 medications are prepared by appropriately licensed pharmacies or eligible outsourcing facilities under applicable federal and state requirements. They are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication. The FDA does not review compounded drugs for safety, effectiveness, or quality before marketing in the same way it reviews FDA-approved medications. Compounding is subject to regulatory restrictions, including conditions relating to the availability of FDA-approved alternatives and whether a patient's medical needs can be met by an approved product. Women should discuss potential risks, regulatory differences, and treatment alternatives with a licensed physician.
Can GLP-1 programs help women with PCOS, perimenopause, or thyroid conditions?
Women with PCOS, perimenopause, menopause, or thyroid conditions may be eligible for GLP-1 treatment when they meet relevant clinical criteria. These conditions require individualized evaluation and do not automatically establish eligibility. Programs with women's hormonal health expertise may be better positioned to discuss the interaction between weight management and these conditions. Certain thyroid cancer histories are important contraindications for specific FDA-approved GLP-1 medications. Women should disclose personal and family medical histories, current medications, and pregnancy plans before treatment. Medication selection and treatment decisions remain the responsibility of the prescribing clinician.
Is my GLP-1 prescription covered by insurance?
Coverage varies according to the medication, medical indication, and insurance plan. Many compounded GLP-1 programs operate on a self-pay basis, while some platforms help patients seek coverage for FDA-approved products. HSA or FSA funds may be usable for eligible medical expenses, depending on plan rules. The Medicare GLP-1 Bridge began July 1, 2026, and is scheduled to run through December 31, 2027. Eligible Part D beneficiaries can access certain FDA-approved medications with a $50 monthly copayment, subject to the program's clinical and administrative requirements. The Bridge does not cover compounded GLP-1 medications. Majesta Health does not bill insurance. Women should verify benefits, total costs, and eligibility with their insurer or program before enrolling.
Sources
- 1.New Weight Loss Drugs. 2025. Original survey research · RAND Corporation · accessed
- 2.KFF Health Tracking Poll. November 2025. Original survey research · KFF · accessed
- 3.Medicare GLP-1 Bridge. 2026. Official program information · Centers for Medicare & Medicaid Services · accessed
- 4.Compounding and the FDA. Regulatory guidance · U.S. Food and Drug Administration · accessed
- 5.FDA's Concerns With Unapproved GLP-1 Drugs Used for Weight Loss. Medication safety guidance · U.S. Food and Drug Administration · accessed
- 6.Zepbound Prescribing Information. Official prescribing information · DailyMed, U.S. National Library of Medicine · accessed
- 7.Wegovy Prescribing Information. Official prescribing information · DailyMed, U.S. National Library of Medicine · accessed
- 8.Prescription Weight-Loss Medications. Clinical guidance · National Institute of Diabetes and Digestive and Kidney Diseases · accessed
Is this available in your state?
Telehealth rules differ by state, and so does what a physician can prescribe remotely. Each state page covers the local telehealth requirements, whether a video visit is required, and the current status of our physician coverage there.
- California
- Texas
- Florida
- New York
- Pennsylvania
- Illinois
- Ohio
- Georgia
- North Carolina
- Michigan
- Arizona
- Washington
